Alvin F. Wong is Chief Scientific Officer at PUMA BIOTECHNOLOGY, INC. (PBYI). They have made 5 open-market trades across 1 company since 2021, most recently 2024-02-12.
CIK 0001868855
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PBYI | 141,241 | $1.5M |
Shares reported on the most recent Form 4, priced at the 2024-02-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PBYI | SELL · 10b5-1 | 2024-01-03 | 2024-01-05 | $4.49 | $35K | +7.3% | +2.3% | +15.5% |
| PBYI | SELL · 10b5-1 | 2023-12-04 | 2024-01-10 | $3.76 | $1K | +5.0% | +21.2% | +22.2% |
| PBYI | SELL · 10b5-1 | 2023-07-03 | 2023-07-06 | $3.31 | $23K | +7.8% | +28.3% | -19.9% |
| PBYI | SELL · 10b5-1 | 2023-06-02 | 2023-06-06 | $3.45 | $928 | -0.6% | -13.3% | -1.4% |
| PBYI | SELL | 2023-01-03 | 2023-01-05 | $4.18 | $14K | -5.2% | -2.8% | -40.6% |
| PBYI | SELL | 2022-12-02 | 2022-12-06 | $4.50 | $2K | +15.3% | +8.2% | -29.2% |
| PBYI | SELL | 2022-07-05 | 2022-07-07 | $2.63 | $8K | +17.9% | +24.6% | -12.9% |
| PBYI | SELL | 2022-06-02 | 2022-06-06 | $1.92 | $1K | +10.5% | +16.3% | +3.3% |
| PBYI | SELL | 2021-12-02 | 2021-12-06 | $2.91 | $3K | +6.6% | -3.7% | -19.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.